← 產業報告目錄
Pharmaceutical Contract Sales Outsourcing [CSO] Market Size, Share & Trends Analysis Report By Service (Personal Promotion (Promotional Sales Team (Dedicated Sales Team, Syndicated Sales Team), Key Account Management, Vacancy Management), Non-personal Promotion, Others), By Therapeutic Area, By Region, And by Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-22頁數 180報告編號 INSIGHTACE-0a63ec8dbd
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Pharmaceutical Contract Sales Outsourcing [CSO] Market worldwide was assessed at USD 10.80 Bn. Analysts project it will develop to USD 25.80 Bn by 2034, at a CAGR of 9.2% spanning 2025 to 2034.
At its core, Pharmaceutical Contract Sales Outsourcing [CSO] pertains to the practice of pharmaceutical companies partnering with external organizations to handle various aspects of their sales and marketing efforts. Stakeholders across the healthcare landscape are risingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region anticipated to deliver the strongest growth trajectory through the forecast period, supported by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharmaceutical Contract Sales Outsourcing [CSO] Market Snapshot
Chapter 4. Global Pharmaceutical Contract Sales Outsourcing [CSO] Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Service Estimates & Trend Analysis
5.1. By Service, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Service:
5.2.1. Personal Promotion
5.2.1.1. Promotional Sales Team
5.2.1.1.1. Dedicated Sales Team
5.2.1.1.2. Syndicated Sales Team
5.2.1.2. Key Account Management
5.2.1.3. Vacancy Management
5.2.2. Non-personal Promotion
5.2.2.1. Tele-detailing
5.2.2.2. Interactive E-detailing
5.2.2.3. Customer Service
5.2.2.4. Medical Science Liaisons
5.2.2.5. Patient Engagement Services
5.2.2.6. Others
5.2.3. Others
Chapter 6. Market Segmentation 2: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Therapeutic Area:
6.2.1. Cardiovascular Disorders
6.2.2. Oncology
6.2.3. Metabolic Disorders
6.2.4. Neurology
6.2.5. Orthopedic Diseases
6.2.6. Infectious Diseases
6.2.7. Others
Chapter 7. Pharmaceutical Contract Sales Outsourcing [CSO] Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) estimates and forecasts By Service, 2021-2034
7.1.2. North America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
7.1.3. North America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Service, 2021-2034
7.2.2. Europe Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Therapeutic Area, 2021-2034
7.2.3. Europe Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Service, 2021-2034
7.3.2. Asia Pacific Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Therapeutic Area, 2021-2034
7.3.3. Asia Pacific Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
7.4.2. Latin America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
7.4.3. Latin America Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Service, (US$ Million) 2021-2034
7.5.2. Middle East & Africa Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) By Therapeutic Area, (US$ Million) 2021-2034
7.5.3. Middle East & Africa Pharmaceutical Contract Sales Outsourcing [CSO] Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Ashfield (UDG Healthcare plc)
8.2.2. inVentiv Health, Inc. (Syneos Health)
8.2.3. IQVIA
8.2.4. Granard Pharmaceutical Sales & Marketing
8.2.5. Vanguard Pharma, Inc.
8.2.6. GTS Solution
8.2.7. EVERSANA
8.2.8. MaBiCo
8.2.9. QFR Solutions
8.2.10. Pharmaforce Ireland Ltd.
8.2.11. Sales Focus, Inc.
8.2.12. Amplity Health
8.2.13. PharmaLex GmbH
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們